April 2026

We are proud to announce that eight local pharmaceutical companies have successfully cleared stringent international quality audits this week. This achievement is more than just a certificate; it is a gateway to high-value regulated markets in Europe and North America. This milestone brings us one step closer to our long-term goal: transforming Pakistan into a

The Drug Regulatory Authority of Pakistan (DRAP) has issued new advisories urging pharmaceutical manufacturers to adopt Multiple Sourcing Strategies for raw materials. By diversifying our supply chains, the industry is building the resilience needed to navigate global logistical challenges and ensure that essential medicines remain available to the public without interruption. PPMA remains committed to

Pakistan’s pharmaceutical sector is shifting from a domestic focus to becoming a high-value global player. At the Pak Pharma & Healthcare Expo 2026, top industry leaders and regulatory experts outlined the roadmap for export expansion: Key Discussion Pillars: Analytical Excellence: Elevating quality control to meet international benchmarks.Digital Integration: Implementing smart compliance systems for global regulatory

Good news for the healthcare sector. The Drug Regulatory Authority of Pakistan (DRAP) has officially confirmed that there are no price increases for essential medicines. Despite recent rumors, the supply chain for life-saving drugs is reported as “satisfactory” for the coming months, ensuring both affordability and availability for the general public.